Journal: Health Affairs Forefront
Citation: Neumann PJ and Cohen JT "Are We Valuing Prescription Drugs Appropriately?", Health Affairs Forefront, February 5, 2024. DOI: 10.1377/forefront.20240130.833652
We argue that methods for valuing drug therapies need updating. Such improvements would make the estimated value of some, although not all, prescription drugs more favorable in economic assessments. In the long run, these improvements will have the effect of promoting the continued development of drugs that produce health benefits that are worth more than what society must spend to invent those drugs in the first place.
